Saint-Maurice PF, Troiano RP, Bassett DR et al (2020) Association of daily step count and step intensity with mortality among US adults
If you live with type 1 diabetes, chances are you've heard about GLP-1 medications Ozempic, Wegovy, Mounjaro mostly in the context of weight loss or type 2 diabetes
On the heels of Regenerons combinations, Scholar Rocks released results from EMBRAZE, a 24-week Phase 2 study of tirzepatide with or without their anti-(latent) myostatin antibody, apetigromab
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 183,71 per year only 15,31 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Despite the promise, it is not approved for weight loss specifically
Every shipment includes everything you need to self-administer at home, clearly labeled and prepared
